RoslinCT and Ayrmid Pharma Intend to Partner to Manufacture FDA-Approved Cell Therapy Omisirge The cell-based product is a nicotinamide modified allogeneic hematopoietic progenitor cell therapy that was FDA-OK'd and launched in 2023. #AyrmidPharma #CellTherapy #GeneEditing https://hubs.li/Q03bhyTb0
Genetic Engineering & Biotechnology News
Book and Periodical Publishing
New Rochelle, New York 181,012 followers
The Bedrock of Biotech
About us
Genetic Engineering & Biotechnology News (GEN) is the flagship publication of Mary Ann Liebert, Inc. Celebrating its 40th anniversary in 2021, GEN was the first publication in this field and remains the key driver in the explosion of the industry, paving the way for the development of new tools and technologies, investment growth, and career opportunities. Through its cornerstone Magazine, dynamic Website, high-frequency eNewsletters, and innovative suite of multimedia, GEN is the 360-degree resource that researchers and executives depend on for information that is pivotal for their success. GEN’s breadth of editorial coverage is unrivaled, providing exclusive reporting, insight, and analysis across the life sciences – from its five foundational pillars of Drug Discovery, Bioprocessing, OMICS, Translational Medicine, and Gene Editing to a new, expanded focus on the emerging areas of Cancer Research, Infectious Diseases, and Artificial Intelligence. Within these areas, GEN delivers exclusive, high-quality reporting on the latest industry news; insider information on cutting-edge tools and technologies; industry-standard protocols, tutorials, and technical articles; first-looks at emerging industry collaborations and investments; reports from key scientific and industry meetings; and A-Lists, our monthly insight and analysis into the top companies, products, and movers & shakers impacting the industry today.
- Website
-
http://www.genengnews.com
External link for Genetic Engineering & Biotechnology News
- Industry
- Book and Periodical Publishing
- Company size
- 51-200 employees
- Headquarters
- New Rochelle, New York
- Type
- Privately Held
- Founded
- 1981
- Specialties
- Biotechnology, Drug Discovery, Bioprocessing, Translational Medicine, OMICS, and Genome Editing
Locations
-
Primary
Get directions
140 Huguenot St
New Rochelle, New York 10801, US
Employees at Genetic Engineering & Biotechnology News
Updates
-
Without Fundamental Science, How Will the Next Generation of Novel Therapies Emerge? Quantifying the contribution of governmental grants to modern medicine in a new climate of uncertainty and shifting research priorities. Don't miss this guest commentary by Eirini Vamva, PhD. #DrugDiscovery #pharmaceutical The National Institutes of Health
-
In Vivo Base Editing Gets Boost with Positive Initial Data Announced by Beam Therapeutics The base editing company, Beam Therapeutics, announced positive initial data for BEAM-302 in the Phase I/II trial in Alpha-1 Antitrypsin Deficiency (AATD), demonstrating first ever clinical genetic correction of a disease-causing mutation.
-
Sex Hormone Protects Against Opioid Misuse in Female Rats Findings from Washington University School of Medicine in St. Louis indicate that differences in how men and women use and misuse #opioids may be driven by their #hormones, and that a deeper understanding of how sex hormones interact with chronic pain could open up new approaches to addressing the opioid epidemic.
-
Regular Blood Donations May Trigger Beneficial Genetic Changes in Bone Marrow Stem Cells New research shows that mutations in DNMT3A in blood stem cells of frequent blood donors may bolster the production of noncancerous cells. The researchers are from The Francis Crick Institute in collaboration with colleagues from from DKFZ German Cancer Research Center and the Deutsches Rotes Kreuz. #camcer #StemCells #blood
-
NEW GEN Live! How Lab Automation Is Advancing Biotech Broadcast Date: Wednesday, March 19, 2025 Time: 9:00 am PT, 12:00 pm ET, 17:00 CET On this episode of GEN Live, we will discuss the role of automation now and what the future looks like. Register now to join us for this free GEN Live: https://hubs.li/Q039-v-N0 Emma Norris Rachael Cohen #Bioprocessing #Automation
-
-
Roche Genentech Innovation Center Boston Launched at Harvard’s Enterprise Research Campus The hub has also been created to strengthen an existing relationship between Harvard University and Roche that has been in place for over a decade. #DrugDiscovery
-
iRNAs May Provide New Approach to Fight Antibiotic-Resistant Bacterial Infections Exosomal siRNAs were shown to be efficiently delivered into bacterial cells and can silence target genes primarily through translational repression without mRNA degradation. It might be possible to use this approach to target multi-drug resistant bacterial infections. #InfectiousDisease #AntibioticResistant
-
Motion Sickness Brain Circuit Linked to Obesity in Mice Researchers suggest a better understanding of the neural basis for thermoregulation during motion sickness may provide unconventional targets for #obesity treatment. Baylor College of Medicine